Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
SBI Healthcare Opp Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.12.86902500000445.2250
Domestic EquitiesDivi's Laboratories Ltd.6.4231360000222.2172
Domestic EquitiesCipla Ltd.5.67511280000196.3392
Domestic EquitiesMax Healthcare Institute Ltd.5.66382000000195.9500
Domestic EquitiesLupin Ltd.4.7421800000164.0600
Domestic EquitiesPolymedicure Ltd.4.0215500000139.1300
Domestic EquitiesKrishna Institute of Medical Sciences Ltd.3.74892200000129.7010
Domestic EquitiesJupiter Life Line Hospitals Ltd.3.6414832871125.9801
Domestic EquitiesAether Industries Ltd.3.32891400000115.1710
Domestic EquitiesAmi Organics Ltd.3.2519525000112.5049
Domestic EquitiesMankind Pharma Ltd.2.9612400000102.4480
Domestic EquitiesRainbow Children's Medicare Ltd.2.9402640000101.7216
Domestic EquitiesAster DM Healthcare Ltd.2.8901200000099.9900
Domestic EquitiesAbbott India Ltd.2.88483600099.8042
Domestic EquitiesTorrent Pharmaceuticals Ltd.2.882530000099.7260
Domestic EquitiesFortis Healthcare Ltd.2.8581150000098.8800
Domestic EquitiesAurobindo Pharma Ltd.2.737175000094.6950
Domestic EquitiesGland Pharma Ltd.2.712754000093.8520
Domestic EquitiesAlkem Laboratories Ltd.2.446415000084.6368
Domestic EquitiesSuven Pharmaceuticals Ltd.2.038154000070.5132
Domestic EquitiesVijaya Diagnostic Centre Ltd.2.023360000069.9990
Domestic EquitiesLaurus Labs Ltd.1.9672120000068.0580
Domestic EquitiesBiocon Ltd.1.5832150000054.7725
Domestic EquitiesAkums Drugs & Pharmaceuticals Ltd.1.456183253250.3765
Domestic EquitiesGufic Biosciences Ltd.1.1968100000041.4050
Domestic EquitiesPfizer Ltd.1.15057491139.8021
Domestic EquitiesSanofi Consumer Healthcare India Ltd.1.04617500036.1905
Domestic EquitiesDr. Lal Path labs Ltd.0.954510997433.0241
Domestic EquitiesConcord Biotech Ltd.0.019231190.6636
Total 92.1135 3186.8365
Cash & Cash Equivalents and Net AssetsTREPS3.5395 122.4540
Cash & Cash Equivalents and Net AssetsNet Receivable / Payable-0.0404 -1.3983
Total 3.4990 121.0557
Overseas EquitiesLonza Group4.3874300000151.7906
Total 4.3874 151.7906
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.